These compounds may interact with:
Receptor tyrosine-protein kinase erbB-3
Potentially involved in: kidney cancer; carcinoma; type 1 diabetes mellitus; alopecia areata; cancer; arthrogryposis; bipolar disorder; mental depression; edema; gallbladder neoplasm; polyhydramnios; hydronephrosis; lung neoplasms; micrognathism; prostatic neoplasms; schizophrenia; unipolar depression; akinesia; muscle degeneration; reduced fetal movement
Disease data sourced from Pharos.